NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 2, 2026 — Lice Happens Atlanta offers chemical-free, mobile lice removal safe for pregnant women, kids, and sensitive skin. Achieves 95% success rate without pesticides or resistance risks.
April 2, 2026 — HeartBeam stock upgraded to Buy after FDA clears its portable 12-lead ECG tech. Analyst raises price target to $4, citing the company's shift to commercialization.
April 2, 2026 — Dr. Razi brings world-class braces and Invisalign to Naperville, IL, with personalized care for all ages. Learn about expert orthodontic treatments and patient-centered service at Razi Orthodontics.
April 2, 2026 — Dr. Razi of Razi Orthodontics provides personalized braces and Invisalign treatment in Wheaton IL with compassionate care, flexible financing, and free consultations for confident smiles.
April 2, 2026 — Visory Health ranks among top 3 U.S. prescription discount platforms, saving users up to 80% on medications at 37,000+ pharmacies. Learn how this health tech platform increases affordability.
April 2, 2026 — Mordor Intelligence report forecasts cancer immunotherapy market to reach $311.4B by 2031, driven by research from firms like Calidi Biotherapeutics and supportive regulations.
April 2, 2026 — Oncotelic Therapeutics partners with TechForce Robotics to commercialize AI-enabled robotics platform for pharmaceutical manufacturing, combining AI capabilities with robotics expertise for automated compliance solutions.
April 2, 2026 — American Heart Association & NFL to train thousands in free Hands-Only CPR at 2026 NFL Draft in Pittsburgh. Join Damar Hamlin to learn lifesaving skills in 90 seconds.
April 2, 2026 — Soligenix's HyBryte shows 60% treatment success vs. 20% for Valchlor in CTCL study, with no adverse events. A breakthrough in photodynamic therapy for rare cancer.
April 2, 2026 — NurExone Biologic wins BOLD Awards healthcare category for exosome therapies and partners with Investor Brand Network to boost investor outreach, advancing CNS injury treatments.
April 2, 2026 — Lantern Pharma hosts investor briefing on withZeta.ai, the first multi-agentic AI co-scientist for rare cancer drug discovery, showcasing its RADR platform and growth roadmap.
April 2, 2026 — CIRM achieves historic milestone with first FDA-approved therapy from California taxpayer funding. KRESLADI gene therapy treats rare LAD-I disease in children with 100% survival rate in trials.
April 2, 2026 — Sigyn Therapeutics launches initiative to evaluate CardioDialysis and other technologies for diagnosing and treating CTE in former NFL players, targeting chronic inflammation as a key disease driver.
April 1, 2026 — Cardio Diagnostics Holdings uses AI and biomarkers to revolutionize heart disease detection with simple blood tests. Learn about their CMS-approved technology and global expansion.
April 1, 2026 — Soligenix reports 2025 results, advancing HyBryte™ for cutaneous T-cell lymphoma and orphan drug designation for Behçet’s Disease. Explore rare disease pipeline updates and strategic developments.
April 1, 2026 — LIXTE Biotechnology's LB-100 is the world's only clinical-stage PP2A inhibitor, enhancing cancer treatment effectiveness while disrupting tumor repair systems in Phase 1 trials.
April 1, 2026 — Soligenix publishes HyBryte™ therapy clinical summary in peer-reviewed journal, enhancing credibility for cutaneous T-cell lymphoma treatment through scientific validation and transparency.
April 1, 2026 — Scientists overcome 50-year production barriers for doxorubicin, a key cancer drug, by engineering bacteria to yield 180% more. This breakthrough promises cheaper, more accessible chemotherapy.
April 1, 2026 — NanoViricides announces Phase II trial for MPox treatment NV-387 in DRC, advancing antiviral therapy with FDA Orphan Drug Designation sought. Read more on InvestorWire.
April 1, 2026 — Stonegate Capital Partners updates coverage on Alpha Cognition (NASDAQ: ACOG), highlighting ZUNVEYL's strong revenue growth and increasing adoption in long-term care facilities with 62% quarterly bottle increase.